GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RIV Capital Inc (XCNQ:RIV) » Definitions » Gross Margin %

RIV Capital (XCNQ:RIV) Gross Margin % : -23.87% (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is RIV Capital Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. RIV Capital's Gross Profit for the three months ended in Sep. 2024 was C$-1.57 Mil. RIV Capital's Revenue for the three months ended in Sep. 2024 was C$6.58 Mil. Therefore, RIV Capital's Gross Margin % for the quarter that ended in Sep. 2024 was -23.87%.


The historical rank and industry rank for RIV Capital's Gross Margin % or its related term are showing as below:

XCNQ:RIV' s Gross Margin % Range Over the Past 10 Years
Min: -15.63   Med: 0   Max: 0
Current: -15.63


XCNQ:RIV's Gross Margin % is ranked worse than
98.25% of 969 companies
in the Drug Manufacturers industry
Industry Median: 47.02 vs XCNQ:RIV: -15.63

RIV Capital had a gross margin of -23.87% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for RIV Capital was 0.00% per year.


RIV Capital Gross Margin % Historical Data

The historical data trend for RIV Capital's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RIV Capital Gross Margin % Chart

RIV Capital Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22
Gross Margin %
- - - - -

RIV Capital Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.01 5.81 28.68 -41.31 -23.87

Competitive Comparison of RIV Capital's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, RIV Capital's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RIV Capital's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RIV Capital's Gross Margin % distribution charts can be found below:

* The bar in red indicates where RIV Capital's Gross Margin % falls into.



RIV Capital Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

RIV Capital's Gross Margin for the fiscal year that ended in Mar. 2022 is calculated as

Gross Margin % (A: Mar. 2022 )=Gross Profit (A: Mar. 2022 ) / Revenue (A: Mar. 2022 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

RIV Capital's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=-1.6 / 6.582
=(Revenue - Cost of Goods Sold) / Revenue
=(6.582 - 8.153) / 6.582
=-23.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


RIV Capital  (XCNQ:RIV) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

RIV Capital had a gross margin of -23.87% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


RIV Capital Gross Margin % Related Terms

Thank you for viewing the detailed overview of RIV Capital's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


RIV Capital Business Description

Traded in Other Exchanges
Address
40 King Street West, Suite 2504, Toronto, ON, CAN, M5H 3Y2
RIV Capital Inc is a venture capital investment and operating platform structured to pursue investment opportunities in the cannabis sector. The company has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the cannabis sector. The investments take the form of production-linked royalties, secured debt, newly formed joint ventures, and a variety of equity and equity-linked instruments.
Executives
David Ernest Vautrin Senior Officer
Michael Quinn Totzke Ii Senior Officer
Jason Wild 10% Security Holder
Asha Daniere Director
Joseph Mimran Director
Richard P. Mavrinac Director
Edward James Cirillo Lucarelli Senior Officer